Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Clinical trial NCT03202992 · COMPLETED

Trial details

NCT number: NCT03202992
Sponsor: Antiva Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HSIL, High-Grade Squamous Intraepithelial Lesions Human Papilloma Virus Infection HIV Infection Anal Cancer Anus Neoplasms

Start date: 2017-08-11
Primary completion: 2019-02-04
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.